Cell Therapy

News

Tenpoint raises $70m for vision loss therapies

UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for

News

FDA approves first cell therapy for type 1 diabetes

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors.

News

Nkarta tweaks regimen in bid to revive AML programme

Last year, Nkarta was celebrating data which showed that its natural killer (NK) cell therapy for acute myeloid leukaemia (AML) was showing remarkable efficacy in hard-to-

News

BioSenic slumps as it sidelines bone repair therapy

Belgian biotech BioSenic has suspended a phase 2b trial of ALLOB – a stem cell-derived therapy designed to accelerate bone fracture healing – after it was unable to show e

News

AstraZeneca inks $2bn Treg cell therapy deal with Quell

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which

News

Iovance eyes November FDA decision on melanoma cell therapy

Iovance Biotherapeutics could be a few months away from a first regulatory approval for lifileucel, which could be the first cell-based therapy for a solid tumour in the U

Tenpoint raises $70m for vision loss therapies

FDA approves first cell therapy for type 1 diabetes

Nkarta tweaks regimen in bid to revive AML programme

BioSenic slumps as it sidelines bone repair therapy

AstraZeneca inks $2bn Treg cell therapy deal with Quell

Iovance eyes November FDA decision on melanoma cell therapy

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Cell Therapy

Editor's Picks